Driving the Business Case for Quality through Balancing Reducing Expenditure While Maintaining Quality, Taking a Risk Based Approach to Complaint Handling & Deviation Management, all while Managing Increasingly Complex Global Supplier Relationships in an Evolving Regulatory Environment
ABOUT THE CONFERENCE
Throughout the medical device industry, corporations are continually looking to reduce the overall cost of producing high-quality medical devices, and look towards quality assurance executives to mitigate risk and maintain pristine levels of quality all while reducing expenditures. At the same time, the FDA along with other global regulatory agencies are increasing the level of regulatory scrutiny alongside increased numbers of audits, inspections and resulting warning letters, setting industry executives unclear on how to best maintain compliance. Through a conference program designed to provide insight and clarity into leading corporations, the Q1 Medical Device Quality Assurance program will provide executives with an unrivaled educational and networking platform.
Of critical importance within the conference program will be several modules designed to target key learning objectives for the audience, the first of which will focus on regulatory challenges, from new ISO revisions to recent engagements with FDA during audits and an analysis of enforcement trends. The second module will focus on complaints and deviations, taking risk-based approaches to handling quality non-conformance and conducting trend analysis, from conducting effective root cause analysis to planning and conducting CAPAs. Supplier quality assurance will round out the third module of the meeting, with presentations focused on qualification, auditing and monitoring, change management, and the increasing number of global suppliers.
Eric Jahnke | Marketing Manager | Q1 Productions
312.955.0424 | email@example.com